Detalhe da pesquisa
1.
Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients.
Ann Hematol
; 100(10): 2575-2584, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324021
2.
Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 25(8): 1550-1559, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30880268
3.
Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies.
Ann Hematol
; 98(5): 1225-1235, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30923997
4.
Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(11): 2337-2343, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29753838
5.
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 97(2): 335-342, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29151133
6.
Sorafenib and azacitidine as salvage therapy for relapse of FLT3-ITD mutated AML after allo-SCT.
Eur J Haematol
; 98(4): 348-354, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27893163
7.
Causes of death in 2877 patients with myelodysplastic syndromes.
Ann Hematol
; 95(6): 937-44, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27025507
8.
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Group.
Biol Blood Marrow Transplant
; 21(4): 653-60, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25540937
9.
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.
Blood
; 121(15): 3005-15, 2013 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23372164
10.
Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.
Eur J Haematol
; 95(3): 181-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600827
11.
Comparison of cytomorphology and histomorphology in myelodysplastic syndromes.
Front Oncol
; 14: 1359115, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38665949
12.
Validation of a novel algorithm with a high specificity in ruling out MDS.
Int J Lab Hematol
; 46(3): 510-514, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38284270
13.
Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry.
Cancers (Basel)
; 16(4)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38398198
14.
Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies.
Cancers (Basel)
; 16(3)2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339283
15.
Myelodysplastic Syndromes: New Methods of Diagnosis, Prognostication, and Treatment
Dtsch Arztebl Int
; 120(12): 203-210, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36718105
16.
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.
Cancers (Basel)
; 15(14)2023 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509235
17.
In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation.
Nat Med
; 29(3): 583-587, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807684
18.
Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS).
Cancers (Basel)
; 14(8)2022 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454847
19.
Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations.
Cancers (Basel)
; 14(9)2022 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565276
20.
Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods.
Blood Adv
; 6(10): 3006-3010, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35026836